Publicaciones (152) Publicaciones de Javier Arbizu Lostao

2024

  1. Agrypnia Excitata and Supranuclear Vertical Gaze Palsy Linked to Anti-Ma Encephalitis

    Movement Disorders Clinical Practice, Vol. 11, Núm. 5, pp. 571-574

  2. EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 51, Núm. 7, pp. 1891-1908

2023

  1. Case-Based Guide for Image Interpretation and Reporting

    Molecular Imaging of Neurodegenerative Disorders (Springer International Publishing), pp. 255-334

  2. Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, Núm. 8, pp. 2486-2500

  3. Sporadic Creutzfeldt–Jakob disease is associated with reorganization of metabolic connectivity in a pathological brain network

    European Journal of Neurology, Vol. 30, Núm. 4, pp. 1035-1047

2022

  1. Update on the diagnosis of encephalitis

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 4, pp. 247-257

2021

  1. Autoimmune glial fibrillary acidic protein astrocytopathy: case report of a treatable cause of rapidly progressive dementia

    Journal of Neurology

  2. Case 11: Corticobasal Syndrome: [18F]FDG and Amyloid PET

    Clinical Nuclear Medicine in Neurology: an Atlas of Challenging Cases (Springer International Publishing), pp. 55-58

  3. Case 14: Creutzfeldt–Jakob Disease with Pathological Confirmation

    Clinical Nuclear Medicine in Neurology: an Atlas of Challenging Cases (Springer International Publishing), pp. 69-73

  4. Case 20: Autoimmune Encephalitis with Unusual Antibodies

    Clinical Nuclear Medicine in Neurology: an Atlas of Challenging Cases (Springer International Publishing), pp. 99-103

  5. Case 29: Primary Brain Lymphoma

    Clinical Nuclear Medicine in Neurology: an Atlas of Challenging Cases (Springer International Publishing), pp. 141-145

  6. Case 2: Alzheimer’s Disease—[18F] FDG, Tau, and Amyloid PET

    Clinical Nuclear Medicine in Neurology: an Atlas of Challenging Cases (Springer International Publishing), pp. 9-13

  7. Case 9: Progressive Supranuclear Palsy: Richardson Syndrome and Parkinsonian Variants

    Clinical Nuclear Medicine in Neurology: an Atlas of Challenging Cases (Springer International Publishing), pp. 45-50

  8. Evaluation of the role of thyroid scintigraphy in the differential diagnosis of thyrotoxicosis

    Clinical Endocrinology, Vol. 94, Núm. 3, pp. 466-472

  9. Finding our way through the labyrinth of dementia biomarkers

    European Journal of Nuclear Medicine and Molecular Imaging

  10. [18F]-FDG PET imaging in autoimmune GFAP meningoencephalomyelitis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 3, pp. 947-948

2020

  1. 18F-FDG-PET Imaging Patterns in Autoimmune Encephalitis: Impact of Image Analysis on the Results

    Diagnostics, Vol. 10, Núm. 6

  2. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

    The Lancet Neurology, Vol. 19, Núm. 11, pp. 951-962

  3. Caspr2 antibody-associated limbic encephalitis: contribution of visual aided analysis of 18F-FDG PET images using normal database comparison

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 2, pp. 92-95

  4. Current role of 18F-FDG-PET in the differential diagnosis of the main forms of dementia

    Clinical and Translational Imaging, Vol. 8, Núm. 3, pp. 127-140